Medibio Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medibio Ltd with three other
pharmaceutical manufacturers in Australasia:
Regeneus Ltd
(2020
sales of 1.66 million Australian Dollars [US$1.17 million]
),
Prescient Therapeutics Ltd
(70,361.00 Australian Dollars [US$49,584.80 ]
of which 100%
was Clinical stage oncology), and
Recce Pharmaceuticals Ltd
(1.15 million Australian Dollars [US$808,687.34 ]
of which 100%
was RESEARCH AND DEVVELOPMENT OF PHARMACEUTI).
Sales Analysis.
Sales fell dramatically in 2020:
Medibio Ltd reported sales of A$932,831.00 (US$657.38 thousand)
for the
fiscal
year ending
June of 2020.
This
represents
a
sharp
decrease of 77.4%
versus 2019, when the company's sales were A$4.13 million.